Stage set for wider use of drug given to Donald Trump

Monoclonal antibodies — Casirivimab and Imdevimab — developed for Covid-19 management by US drug major Regeneron have been included by the World Health Organization (WHO) in its latest guidelines for treating patients with mild as well as severe symptoms. Monoclonal antibodies were used for treating former US President Donald J Trump.